Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India

References

• Lenharo M WHO declares end to COVID-19’s emergency phase. Nature News Article [Internet]. 2023 May 05 [cited 2023 May 25]. Available from: https://www.nature.com/articles/d41586-023-01559-z
   Google Scholar
• Mygov.in [Internet] India: Government of India; [cited 2023 Jun 19]. Available from: https://www.mygov.in/covid-19/
   Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020;395(10229):1054–1062. doi: 10.1016/s0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Pettit NN, Nguyen CT, Lew AK, et al. Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission. BMC Infect Dis. 2021;21(1):516. doi: 10.1186/s12879-021-06219-z
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Sanjuan G, Moreno-García E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83–88. doi: 10.1016/j.cmi.2020.07.041
   PubMed Web of Science ®Google Scholar
• Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive care Med. 2020;46(5):854–887. doi: 10.1007/s00134-020-06022-5
   PubMed Web of Science ®Google Scholar
• Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Bethesda (MD): National Institutes of Health (US); 2021 [cited 2023 May 30]. Available from: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
   Google Scholar
• WHO. Clinical Management Of COVID-19: Living Guideline. Geneva (CH): World Health Organisation; 2023 Jan 13 [cited 2023 May 30]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2023.1
   Google Scholar
• Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–1629. doi: 10.1016/j.cmi.2020.07.016
   PubMed Web of Science ®Google Scholar
• Thapa B, Pathak SB, Jha N, et al. Antibiotics use in hospitalised COVID-19 patients in a tertiary care centre: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2022;60(251):625–630. doi: 10.31729/jnma.7394
   PubMed Web of Science ®Google Scholar
• Spigaglia P. COVID-19 and clostridioides difficile infection (CDI): possible implications for elderly patients. Anaerobe. 2020;64:102233. doi: 10.1016/j.anaerobe.2020.102233
   PubMed Web of Science ®Google Scholar
• Llor C, Ouchi D, Giner-Soriano M, et al. Correlation between previous antibiotic exposure and COVID-19 severity. A population-based cohort study. Antibiotics. 2021;10(11):1364. doi: 10.3390/antibiotics10111364
   Google Scholar
• Rawson TM, Moore LSP, Castro-Sanchez E, et al. COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother. 2020;75(7):1681–1684. doi: 10.1093/jac/dkaa194
   PubMed Web of Science ®Google Scholar
• Huttner BD, Catho G, Pano-Pardo JR, et al. COVID-19: don’t neglect antimicrobial stewardship principles! Clinical microbiology and infection! Clin Microbiol Infect. 2020;26(7):808–810.
   PubMed Web of Science ®Google Scholar
• Vijay S, Bansal N, Rao BK, et al. Secondary infections in hospitalized COVID-19 patients: Indian experience. Infect Drug Resist. 2021;14:1893–1903. doi: 10.2147/idr.S299774
   PubMed Web of Science ®Google Scholar
• Chindhalore CA, SVG GND, Gajbhiye SV, et al. Prescription pattern for antimicrobials and the potential predictors for antibiotics among patients with COVID-19: a retrospective observational study. J Clin Diagnostic Res. 2022;16(9):FC15–FC19.
   Google Scholar
• Khurana S, Singh P, Sharad N, et al. Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: implication on antimicrobial resistance. Indian J Med Microbiol. 2021;39(2):147–153. doi: 10.1016/j.ijmmb.2020.10.014
   PubMed Web of Science ®Google Scholar
• Clinical guidelines for management of COVID-19 patients [Internet]. India: AIIMS/ICMR-COVID-19 National Task Force/Joint Monitoring Group; [cited 2023 May 30]. Available from: https://www.mohfw.gov.in/pdf/ClinicalGuidanceforManagementofAdultCOVID19Patientsupdatedason05thjan2023.pdf
   Google Scholar
• WHO: Anatomic Therapeutic Chemical (ATC) Classification. Geneva (CH): World Health Organization; [cited 2023 May 30]. Available from: https://www.who.int/tools/atc-ddd-toolkit/atc-classification
   Google Scholar
• WHO: 2021 AWaRe classification. Geneva (CH): World Health Organization; [cited 2023 May 30]. Available from: https://www.who.int/publications/i/item/2021-aware-classification
   Google Scholar
• Gyselinck I, Janssens W, Verhamme P, et al. Rationale for azithromycin in COVID-19: an overview of existing evidence. BMJ Open Respir Res. 2021;8(1):e000806. doi: 10.1136/bmjresp-2020-000806
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8. doi: 10.1038/bmt.2012.244
   PubMed Web of Science ®Google Scholar
• Nandi A, Pecetta S, Bloom DE. Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020-2022. EClinicalMedicine. 2023;57:101848. doi: 10.1016/j.eclinm.2023.101848
   PubMedGoogle Scholar
• Rizvi SG, Ahammad SZ. COVID-19 and antimicrobial resistance: A cross-study. Sci Total Environ. 2022;807(Pt 2):150873. doi: 10.1016/j.scitotenv.2021.150873
   PubMedGoogle Scholar
• Vaughn VM, Gandhi TN, Petty LA, et al. Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): a multi-hospital cohort study. Clin Infect Dis. 2021;72(10):e533–e541. doi: 10.1093/cid/ciaa1239
   PubMed Web of Science ®Google Scholar
• Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–464.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;9(1):107. doi: 10.1186/1741-7015-9-107
   PubMedGoogle Scholar
• May M, Chang M, Dietz D, et al. Limited utility of procalcitonin in identifying community-associated bacterial infections in patients presenting with coronavirus disease 2019. Antimicrob Agents Chemother. 2021;65(4). doi: 10.1128/aac.02167-20
   Web of Science ®Google Scholar
• van Berkel M, Kox M, Frenzel T, et al. Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times? Crit Care. 2020;24(1):600.
   PubMed Web of Science ®Google Scholar
• Ahava MJ, Kortela E, Forsblom E, et al. Low incidence of severe bacterial infections in hospitalised patients with COVID-19: a population-based registry study. Infect Dis. 2023;55(2):132–141.
   PubMed Web of Science ®Google Scholar
• Townsend L, Hughes G, Kerr C, et al. Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection. JAC Antimicrob Resist. 2020;2(3):dlaa071. doi: 10.1093/jacamr/dlaa071
   PubMedGoogle Scholar
• Rawson TM, Moore LSP, Zhu N, et al. Bacterial and Fungal Coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–2468. doi: 10.1093/cid/ciaa530
   PubMed Web of Science ®Google Scholar
• Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–275. doi: 10.1016/j.jinf.2020.05.046
   PubMed Web of Science ®Google Scholar
• Baghdadi JD, Coffey KC, Adediran T, et al. Antibiotic use and bacterial infection among inpatients in the first wave of COVID-19: a retrospective cohort study of 64,691 patients. Antimicrob Agents Chemother. 2021;65(11):e0134121. doi: 10.1128/aac.01341-21
   PubMed Web of Science ®Google Scholar
• Nag VL, Kaur N. Superinfections in COVID-19 patients: role of antimicrobials. Dubai Med J. 2021;4(2):81–90. doi: 10.1159/000515067
   Google Scholar
• Moreno-Torres V, de Mendoza C, de la Fuente S, et al. Bacterial infections in patients hospitalized with COVID-19. Intern Emerg Med. 2022;17(2):431–438. doi: 10.1007/s11739-021-02824-7
   PubMed Web of Science ®Google Scholar
• Shah MM, Patel K, Milucky J, et al. Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020-April 2022. Influenza Other Respir Viruses. 2023;17(3):e13107.
   PubMed Web of Science ®Google Scholar
• Gandra S, Tseng KK, Arora A, et al. The mortality burden of multidrug-resistant pathogens in India: a retrospective, observational study. Clin Infect Dis. 2019;69(4):563–570. doi: 10.1093/cid/ciy955
   PubMed Web of Science ®Google Scholar
• Dat VQ, Dat TT, Hieu VQ, et al. Antibiotic use for empirical therapy in the critical care units in primary and secondary hospitals in Vietnam: a multicenter cross-sectional study. Lancet Reg Health West Pac. 2022;18:100306. doi: 10.1016/j.lanwpc.2021.100306
   PubMedGoogle Scholar
• Stevens RW, Jensen K, Kooda K, et al. A retrospective antibiotic prescribing assessment and examination of potential antibiotic stewardship targets in patients with COVID-19. JAC Antimicrob Resist. 2021;3(4):dlab170. doi: 10.1093/jacamr/dlab170
   PubMedGoogle Scholar